Alnylam Pharmaceuticals (ALNY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALNY | AMGN | GILD | BIIB | CELG |
| Company | Alnylam Pharmaceuticals | Amgen Inc | Gilead Sciences Inc | Biogen Inc | Celgene Corp |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 154.41 | 313.39 | 65.51 | 215.30 | 108.01 |
| High | 155.41 | 322.60 | 65.53 | 217.88 | 108.59 |
| Low | 151.84 | 308.68 | 64.33 | 213.11 | 107.27 |
| Last | 152.33 | 311.29 | 64.78 | 217.51 | 108.24 |
| Change | +2.02 | +32.90 | -0.55 | +4.00 | +0.11 |
| % Change | +1.34% | +11.82% | -0.84% | +1.87% | +0.10% |
| Volume | 452,100 | 9,644,601 | 7,822,700 | 1,144,100 | 191,230,496 |
| 20-Day Average Volume | 521,670 | 2,646,885 | 7,406,455 | 1,344,250 | 16,188,930 |
| Previous Close | 150.31 | 278.39 | 65.33 | 213.51 | 108.13 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | No |
| Technicals | |||||
| 20-Day Moving Average | 148.04 | 272.27 | 66.88 | 203.10 | 108.17 |
| 20-Day Raw Stochastic | 59.63% | 81.73% | 8.01% | 95.41% | 63.25% |
| 20-Day Relative Strength | 52.59% | 72.10% | 30.11% | 56.41% | 64.69% |
| Weighted Alpha | -27.14 | +33.76 | -22.64 | -29.51 | +46.30 |
| Today's Opinion | 64% Sell | 24% Buy | 100% Sell | 56% Sell | 100% Buy |
| Previous Opinion | 72% Sell | 16% Sell | 100% Sell | 56% Sell | 100% Buy |
| Last Month's Opinion | 88% Sell | 24% Sell | 100% Sell | 100% Sell | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.29% since 04/26/24 | +15.30% since 04/26/24 | -0.98% since 04/26/24 | +4.12% since 04/26/24 | -1.97% since 11/13/19 |
| Low | 143.50 on 04/29/24 | 268.99 on 04/29/24 | 64.33 on 05/03/24 | 208.54 on 04/29/24 | 107.27 on 11/20/19 |
| High | 155.41 on 05/03/24 | 322.60 on 05/03/24 | 66.91 on 04/29/24 | 218.86 on 04/29/24 | 110.53 on 11/14/19 |
| 1-Month | |||||
| %Chg | +0.99% since 04/03/24 | +13.44% since 04/03/24 | -8.62% since 04/03/24 | +5.39% since 04/03/24 | +5.14% since 10/18/19 |
| Low | 141.98 on 04/25/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 189.44 on 04/19/24 | 102.40 on 10/21/19 |
| High | 159.34 on 04/09/24 | 322.60 on 05/03/24 | 71.39 on 04/04/24 | 218.86 on 04/29/24 | 110.70 on 11/13/19 |
| 3-Month | |||||
| %Chg | -11.98% since 02/02/24 | -3.68% since 02/02/24 | -15.83% since 02/02/24 | -10.75% since 02/02/24 | +13.63% since 08/20/19 |
| Low | 141.98 on 04/25/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 189.44 on 04/19/24 | 93.41 on 08/23/19 |
| High | 173.33 on 02/06/24 | 329.72 on 02/05/24 | 77.87 on 02/06/24 | 246.44 on 02/07/24 | 110.70 on 11/13/19 |
| 6-Month | |||||
| %Chg | -8.98% since 11/03/23 | +15.35% since 11/03/23 | -20.60% since 11/03/23 | -12.82% since 11/03/23 | +14.14% since 05/20/19 |
| Low | 141.98 on 04/25/24 | 260.52 on 11/21/23 | 64.33 on 05/03/24 | 189.44 on 04/19/24 | 89.08 on 07/23/19 |
| High | 199.38 on 01/09/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 268.30 on 01/03/24 | 110.70 on 11/13/19 |
| Key Statistics | |||||
| Market Capitalization, $K | 18,930,942 | 149,321,728 | 81,340,888 | 31,086,416 | 77,035,920 |
| Shares Outstanding, K | 125,946 | 536,376 | 1,245,077 | 145,597 | 711,714 |
| Annual Sales | 1,828,290,000 | 28,190,000,000 | 27,116,000,000 | 9,835,600,000 | 15,281,000,000 |
| Annual Net Income | -440,240,000 | 6,717,000,000 | 5,665,000,000 | 1,161,100,000 | 4,046,000,000 |
| Last Quarter Sales | 439,720,000 | 8,196,000,000 | 6,686,000,000 | 2,290,500,000 | 4,520,000,000 |
| Last Quarter Net Income | -137,870,000 | 767,000,000 | -4,170,000,000 | 393,400,000 | 1,691,000,000 |
| 60-Month Beta | 0.41 | 0.60 | 0.22 | -0.01 | 1.41 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.52 on 05/02/24 | 3.96 on 05/02/24 | -1.32 on 04/25/24 | 3.67 on 04/24/24 | 2.99 on 10/31/19 |
| Latest Earnings Date | 05/02/24 | 05/02/24 | 04/25/24 | 04/24/24 | 10/31/19 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 06/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.87 | 16.26 | 14.41 | 10.99 |